FHIR IG analytics| Package | hl7.fhir.uv.xver-r3.r5 |
| Resource Type | ValueSet |
| Id | ValueSet-R3-v3-ParticipationTargetDirect-for-R5.json |
| FHIR Version | R5 |
| Source | http://hl7.org/fhir/uv/xver-r3.r5/0.1.0/ValueSet-R3-v3-ParticipationTargetDirect-for-R5.html |
| URL | http://hl7.org/fhir/uv/xver/ValueSet/R3-v3-ParticipationTargetDirect-for-R5 |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-03-17T21:02:03.8104715+00:00 |
| Name | R3V3ParticipationTargetDirectForR5 |
| Title | Cross-version ValueSet STU3.ParticipationTargetDirect for use in FHIR R5 |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26` for use in FHIR R5. |
| Purpose | This value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26` as defined in FHIR STU3 in FHIR R5. The source value set is bound to the following FHIR STU3 elements: * Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26`, defined in FHIR STU3 does not have any mapping to FHIR R5 |
No resources found
| CodeSystem | ||
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | ParticipationType | v3-ParticipationType |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R3-v3-ParticipationTargetDirect-for-R5
This value set expansion contains 17 concepts.
| System | Version | Code | Display | Definition |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | ALY | analyte | The target of an Observation action. Links an observation to a Role whose player is the substance or most specific component entity (material, micro-organism, etc.) being measured within the subject. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | BBY | baby | In an obstetric service, the baby. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | CAT | catalyst | The catalyst of a chemical reaction, such as an enzyme or a platinum surface. In biochemical reactions, connects the enzyme with the molecular interaction |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | CSM | consumable | Participant material that is taken up, diminished, altered, or disappears in the act. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | DEV | device | Participant used in performing the act without being substantially affected by the act (i.e. durable or inert with respect to that particular service). |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | DIR | direct target | Target participant that is substantially present in the act and which is directly involved in the action (includes consumed material, devices, etc.). |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | DON | donor | In some organ transplantation services and rarely in transfusion services a donor will be a target participant in the service. However, in most cases transplantation is decomposed in three services: explantation, transport, and implantation. The identity of the donor (recipient) is often irrelevant for the explantation (implantation) service. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | EXPAGNT | ExposureAgent | Description: The entity playing the associated role is the physical (including energy), chemical or biological substance that is participating in the exposure. For example in communicable diseases, the associated playing entity is the disease causing pathogen. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | EXPART | ExposureParticipation | Description:Direct participation in an exposure act where it is unknown that the participant is the source or subject of the exposure. If the participant is known to be the contact of an exposure then the SBJ participation type should be used. If the participant is known to be the source then the EXSRC participation type should be used. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | EXPTRGT | ExposureTarget | Description: The entity playing the associated role is the target (contact) of exposure. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | EXSRC | ExposureSource | Description:The entity playing the associated role is the source of exposure. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | NRD | non-reuseable device | A device that changes ownership due to the service, e.g., a pacemaker, a prosthesis, an insulin injection equipment (pen), etc. Such material may need to be restocked after he service. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | PRD | product | Participant material that is brought forth (produced) in the act (e.g., specimen in a specimen collection, access or drainage in a placement service, medication package in a dispense service). It does not matter whether the material produced had existence prior to the service, or whether it is created in the service (e.g., in supply services the product is taken from a stock). |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | RDV | reusable device | A device that does not change ownership due to the service, i.e., a surgical instrument or tool or an endoscope. The distinction between reuseable and non-reuseable must be made in order to know whether material must be re-stocked. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | SBJ | subject | The principle target on which the action happens. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | SPC | specimen | The subject of non-clinical (e.g. laboratory) observation services is a specimen. |
http://hl7.org/fhir/v3/ParticipationType | 2016-11-11 | TPA | therapeutic agent | Something incorporated in the subject of a therapy service to achieve a physiologic effect (e.g., heal, relieve, provoke a condition, etc.) on the subject. In an administration service the therapeutic agent is a consumable, in a preparation or dispense service, it is a product. Thus, consumable or product must be specified in accordance with the kind of service. |
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "R3-v3-ParticipationTargetDirect-for-R5",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 0
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "fhir"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r3.r5"
},
{
"url": "version",
"valueString": "0.1.0"
},
{
"url": "uri",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r5"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r5"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/xver/ValueSet/R3-v3-ParticipationTargetDirect-for-R5",
"version": "0.1.0",
"name": "R3V3ParticipationTargetDirectForR5",
"title": "Cross-version ValueSet STU3.ParticipationTargetDirect for use in FHIR R5",
"status": "active",
"experimental": false,
"date": "2026-03-17T21:02:03.8104715+00:00",
"publisher": "FHIR Infrastructure",
"contact": [
{
"name": "FHIR Infrastructure",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26` for use in FHIR R5.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26` as defined in FHIR STU3\r\nin FHIR R5.\r\n\r\nThe source value set is bound to the following FHIR STU3 elements:\r\n* \r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\n\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26`, defined in FHIR STU3 does not have any mapping to FHIR R5",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"concept": [
{
"code": "ALY",
"display": "analyte"
},
{
"code": "BBY",
"display": "baby"
},
{
"code": "CAT",
"display": "catalyst"
},
{
"code": "CSM",
"display": "consumable"
},
{
"code": "DEV",
"display": "device"
},
{
"code": "DIR",
"display": "direct target"
},
{
"code": "DON",
"display": "donor"
},
{
"code": "EXPAGNT",
"display": "ExposureAgent"
},
{
"code": "EXPART",
"display": "ExposureParticipation"
},
{
"code": "EXPTRGT",
"display": "ExposureTarget"
},
{
"code": "EXSRC",
"display": "ExposureSource"
},
{
"code": "NRD",
"display": "non-reuseable device"
},
{
"code": "PRD",
"display": "product"
},
{
"code": "RDV",
"display": "reusable device"
},
{
"code": "SBJ",
"display": "subject"
},
{
"code": "SPC",
"display": "specimen"
},
{
"code": "TPA",
"display": "therapeutic agent"
}
]
}
]
},
"expansion": {
"timestamp": "2026-03-17T21:02:03.8104715+00:00",
"contains": [
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "ALY",
"display": "analyte"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "BBY",
"display": "baby"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "CAT",
"display": "catalyst"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "CSM",
"display": "consumable"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "DEV",
"display": "device"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "DIR",
"display": "direct target"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "DON",
"display": "donor"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "EXPAGNT",
"display": "ExposureAgent"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "EXPART",
"display": "ExposureParticipation"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "EXPTRGT",
"display": "ExposureTarget"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "EXSRC",
"display": "ExposureSource"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "NRD",
"display": "non-reuseable device"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "PRD",
"display": "product"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "RDV",
"display": "reusable device"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "SBJ",
"display": "subject"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "SPC",
"display": "specimen"
},
{
"system": "http://hl7.org/fhir/v3/ParticipationType",
"version": "2016-11-11",
"code": "TPA",
"display": "therapeutic agent"
}
]
}
}